Clinical Trials Browser

Terminated × Carcinoma, Non-Small-Cell Lung × brigatinib × Clear all

NCT02706626 2023-01-26

Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors

Phase 2 Terminated

32 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT04005144 2022-10-17

Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Disease Progression